The role of combining the sales of products with high profit margins in improving the profitability of "Djabar" The pharmaceutical company Jaber Ibn Hayyan (Djabar) announced an incredible growth of 280% in net sales in the 9 months that ended in Sharibar 1405, in response to the announcement of the stock exchange organization, and announced that the cost-to-sale ratio also decreased from 71% to 55% with a significant improvement.

The role of combining the sales of products with high profit margins in improving the profitability of "Djabar" The pharmaceutical company Jaber Ibn Hayyan (Djabar) announced an incredible growth of 280% in net sales in the 9 months that ended in Sharibar 1405, in response to the announcement of the stock exchange organization, and announced that the cost-to-sale ratio also decreased from 71% to 55% with a significant improvement.